[ad_1]
Lorenzo Mottola
the December 27 in Italy will start on vaccine distribution against COVID-19, but let’s clarify it immediately: it is not serious. “It will be a symbolic dayOur super commissioner against the pandemic also admitted Domenico Arcuri. What does that mean? That in reality the doses that will be provided to our country will be barely 9,750, enough to undergo treatment less than 5,000 people. The actual campaign will begin, at best, in mid-January. Although now it is clear that the plan will be launched in March and that most of our citizens will have to wait until the summer. The governments of the European Union, however, have reached an agreement to organize the so-called V-day, or a moment in which at the same time in all the countries of the community a volunteer will be injected with the new drug in front of to cameras and photographers. Why this show? Simple, to prevent lagging countries from making a fool of themselves. Not by chance Giuseppe Conte me Roberto Speranza they supported the initiative. A spot that is not very useful, also because to distribute these few roads it will be necessary to activate very complex transport systems.
Videos on this topic
We need frost – Serum Pfizer should be stored in special freezers at -80 degrees. And in some Regions a few hundred units will arrive: in Liguria only 320, in Umbria less than 100, to name two examples. All according to criteria that De Luca himself has called “mysterious”, “one would expect everything to happen as a percentage of the population of the different Regions, but it is not like that.”
The comparison – Let’s make a small comparison: in the United States by the end of the year, 25 million doses of the Pfizer product will have been delivered: one for every 13 inhabitants. Here the ratio is 1 in 6,000. By February, the White House expects to have treated 200 million people. For us it is science fiction: the peak of the third wave is expected in February. The EU is thus trying to cover itself: yesterday another agreement was signed with Moderna for a supply of 80 million serum. This company is the second that has carried out all the necessary tests to be able to commercialize its product. The peculiarity is that it does not have the same storage difficulties as the Pfizer cure, it also resists -2 degrees. Deliveries, in theory, should start in January.
The Moscow Serum – The other point refers to the SputnikNamely, the vaccine produced in Russia, which is already being distributed and which has been purchased in many countries of the world. Argentina has bought large quantities, as has India. In the Union, no one would have bet that Moscow would overtake Western companies, and many laughed when the Kremlin announced that the test phase had ended successfully. However, some are beginning to think that Putin’s cure really works: the Russians yesterday launched the procedures to authorize the sale in the EU. And the German government said it was willing to produce it in Germany. Italy will also have another problem: convincing people to get vaccinated. According to a Silver Observatory survey, only 54% of people over 50 want to get vaccinated. A percentage that does not grow much among those over 65: 59%. And even among doctors there are some skeptics. In fact, the government has started distributing questionnaires in hospitals to assess the availability of staff to take the new drug. In some provinces, the membership was very low: 40% of health workers in South Tyrol refused to participate in the campaign.
[ad_2]
